# Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab

> **NCT01125787** · PHASE2 · TERMINATED · sponsor: **Nevada Cancer Institute** · enrollment: 1 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia (CLL)

## Interventions

- **DRUG:** ofatumumab + bendamustine

## Key facts

- **NCT ID:** NCT01125787
- **Lead sponsor:** Nevada Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2011-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2011-07-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01125787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01125787, "Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01125787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*